Category: Providence Medical Technology
Providence Medical Technology Announces First Patient Enrollment in the “FUSE” IDE Clinical Study
The FUSE Study is designed to demonstrate the superiority of Circumferential Cervical Fusion over traditional ACDF in patients at high risk for nonunion or revisions.
PLEASANTON, Calif., June 15, 2020 /PRNewswire/ — Providence Medical Technology, Inc., a medical device innovator focused on improving surgical outcomes of the cervical spine, announced initiation of enrollment in a human clinical Investigational Device Exemption (IDE) study evaluating the safety and effectiveness of its Posterior Cervical Stabilization System (PCSS) in patients with 3-level degenerative disc disease. The first case was performed by Dr. Pierce Nunley, MD, Director of the Spine Institute of Louisiana in Shreveport, Louisiana.
Providence Medical Technology Secures $25 Million In Equity Financing
Proceeds to Bolster Commercial Expansion & Clinical Development of its DTRAX® Spinal System
Providence Medical Technology Secures New Financing of $10.5 Million From Bridge Bank
Proceeds to further commercialize and expand distribution of cervical fusion technology
WALNUT CREEK, Calif., May 10, 2017 /PRNewswire/ — Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of a $10.5 million debt agreement with Bridge Bank.
“We are pleased that we have partnered with Bridge Bank to bolster our balance sheet with this debt facility,” said Greg Curhan, Chief Financial Officer of Providence. “This financing, coupled with our recently completed equity financing, puts us in a great position to continue to expand our distribution both across the United States as well as in international markets to deliver innovative spinal technology to help patients enjoy pain-free lives.”
Providence Medical Technology Announces Issuance of Four Additional U.S. Patents
Continues Expansion of Cervical Fusion IP Portfolio
WALNUT CREEK, Calif., April 27, 2017 /PRNewswire/ — Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the U.S. Patent Office’s issuance of four additional patents, Nos. 9,622,873; 9,622,791; 9,622,874; and 9,629,665, covering various aspects of its proprietary DTRAX® and CAVUX® posterior cervical spinal fixation technologies.
These patents cover, among other things, posterior placement of an implant in a facet joint using a chisel and guide tube; placement of an implant in a facet joint using a forked guide tube; placement of implants of various configurations in a cervical facet joint; and distraction of a facet joint after posterior placement of an implant in the facet joint.
Providence Medical Technology Closes Series C Financing
Proceeds to Fund Expansion of U.S. Commercialization
LAFAYETTE, Calif. — (BUSINESS WIRE) — Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.
In conjunction with the financing, David Cash of Stanmore and Ned Scheetz of Aphelion have joined Providence’s Board of Directors.
Providence Medical Technology Announces New Equity Financing Of $10.5 Million
Global Healthcare Investor MVM Life Science Partners Leads Round
WALNUT CREEK, Calif., Dec. 19, 2016 /PRNewswire/ – Providence Medical Technology, Inc., an innovator in tissue-sparing, cervical-fusion technology, today announced the closing of $10.5 million in new equity financing for the company. The proceeds will be used to further commercialize and expand its portfolio of cervical-fusion technology.
Providence Medical Technology Announces the Publication of a Technique Paper
Walnut Creek, CA (December 13, 2016) Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the publication of Novel instrumentation and technique for tissue sparing posterior cervical fusion in the Journal of Clinical Neuroscience by Bruce McCormack, MD and Raman Dhawan, MD.
Providence Medical Technology Announces the Launch of CAVUX™ Cervical Cage-L and DTRAX® Spinal System-L
WALNUT CREEK, Calif., Nov. 7, 2016 /PRNewswire/ — Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the commercial launch of its new CAVUX Cervical Cage-L and DTRAX Spinal System-L.
Providence Medical Technology Announces Presentation of Two-Year Outcomes of Posterior Cervical Fusion for Single-Level Cervical Radiculopathy
Walnut Creek, CA (May 20, 2016) ‐‐ Providence Medical Technology, Inc., an innovator in tissue- sparing cervical fusion technology, today announced that its two-year radiographic and clinical outcomes data of posterior cervical fusion using an expandable implant are being presented at Spine Week 2016 in Singapore.
Providence Medical Technology Enhances Cervical Fusion Process With Introduction Of Proprietary Surface Technology to DTRAX Line of Tissue Sparing Devices
LAFAYETTE, Calif. — October 13, 2015 — Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today introduced its proprietary CavuxTM surface technology, designed to speed bone fusion during the healing process. The company’s portfolio of DTRAX® Cervical Cage implants will be available with Cavux, a unique surface technology that produces micro-textures on titanium surfaces. The micro- and nano- textures created across the implant surface area serve to enhance the fusion process.